Key result
Antithrombotic therapy in the elderly requires careful balancing of stroke prevention against fall and bleeding risks, utilizing risk assessment tools and shared decision-making.
Why the study?
In the elderly, accidental deaths are most frequently caused by falls, and antithrombotic therapy prevents cardiovascular events but inevitably carries a risk of bleeding.
In elderly patients, antithrombotic therapy requires a comprehensive approach that balances the prevention of cardiovascular events with the risks of falls and bleeding, utilizing safer agents like DOACs and shared decision making.
Answers are grounded in this paper and cite their sources.
Advocates cautious antithrombotic decisions in elderly via risk tools and shared decision-making; leaves open prospective validation of optimal strategies.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Sugimori et al. (2022) conducted a review in Atrial fibrillation and cardiovascular diseases with fall and bleeding risks. Antithrombotic therapy was evaluated. Antithrombotic therapy in the elderly requires careful balancing of stroke prevention against fall and bleeding risks, utilizing risk assessment tools and shared decision-making.
Synapse has enriched 10 related papers. Consider them for comparative context: